BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9042411)

  • 1. On the origin of spontaneous somatic mutations and sectored plaques detected in transgenic mice.
    Paashuis-Lew Y; Zhang XB; Heddle JA
    Mutat Res; 1997 Feb; 373(2):277-84. PubMed ID: 9042411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Big Blue(R) transgenic mouse mutation detection assay: the mutation pattern of sectored mutant plaques.
    Hill KA; Nishino H; Buettner VL; Halangoda A; Li W; Sommer SS
    Mutat Res; 1999 Mar; 425(1):47-54. PubMed ID: 10082915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
    Hill KA; Buettner VL; Glickman BW; Sommer SS
    Mutat Res; 1999 Jan; 436(1):11-9. PubMed ID: 9878678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
    Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.
    Watson DE; Cunningham ML; Tindall KR
    Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
    Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation is necessary for both repair and mutation in transgenic mouse cells.
    Bielas JH; Heddle JA
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11391-6. PubMed ID: 11005832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a lambda-based complementation assay for the preliminary localization of lacI mutants from the Big Blue mouse: implications for a DNA-sequencing strategy.
    Gu M; Ahmed A; Wei C; Gorelick N; Glickman BW
    Mutat Res; 1994 Jun; 307(2):533-40. PubMed ID: 7514727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence spectra of spontaneous lacZ gene mutations in transgenic mouse somatic and germline tissues.
    Douglas GR; Gingerich JD; Gossen JA; Bartlett SA
    Mutagenesis; 1994 Sep; 9(5):451-8. PubMed ID: 7837979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
    Bielas JH
    Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
    Rogers BJ; Provost GS; Young RR; Putman DL; Short JM
    Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector.
    Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Putman DL; Sorge JA; Short JM
    Environ Mol Mutagen; 1991; 18(4):316-21. PubMed ID: 1836179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel germline mutation in Big Blue mice.
    Crabbe RA; Prtenjaca A; Tarnowski HE; Hill KA
    Environ Mol Mutagen; 2009 Mar; 50(2):114-20. PubMed ID: 19107908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice.
    Winegar RA; Lutze LH; Hamer JD; O'Loughlin KG; Mirsalis JC
    Mutat Res; 1994 Jun; 307(2):479-87. PubMed ID: 7514721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques.
    Nishino H; Buettner VL; Sommer SS
    Mutat Res; 1996 Nov; 372(1):97-105. PubMed ID: 9003536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
    Shane BS; Lockhart AM; Winston GW; Tindall KR
    Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.